Jakob Rath
Medical University of Vienna
37 Papers
86 Citations
Jakob Rath is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 32 publications. Previous affiliations of Jakob Rath include Innsbruck Medical University.
Chat about Author
Papers
Clinical fMRI: Evidence for a 7 T benefit over 3 T
Roland Beisteiner,Simon Robinson,Moritz C. Wurnig,Markus Hilbert,K. Merksa,Jakob Rath,Ilse Höllinger,N. Klinger,Ch. Marosi,Siegfried Trattnig,Alexander Geißler +10 more
TL;DR: It is concluded that ultra high field systems provide a clinically relevant increase of functional sensitivity for patient investigations.
135
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria.
Raffi Topakian,Fritz Zimprich,Stephan Iglseder,Norbert Embacher,Michael Guger,Karl Stieglbauer,Dieter Langenscheidt,Jakob Rath,Stefan Quasthoff,Philipp Simschitz,Julia Wanschitz,David Windisch,Petra Müller,Dierk Oel,Günther Schustereder,Stefan Einsiedler,Christian Eggers,Wolfgang Löscher +17 more
TL;DR: In this retrospective study on RTX for MG, the largest to date, RTX appeared safe, efficacious and fast acting, and Benefit from RTX was greatest in MuSK ab + MG.
73
Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course.
Hakan Cetin,Jakob Rath,Judith Füzi,Berthold Reichardt,Gerhard Fülöp,Stefan Koppi,Marcus Erdler,Gerhard Ransmayr,Jörg Weber,Kurt Neumann,Michael Hagmann,Wolfgang Löscher,Eduard Auff,Fritz Zimprich +13 more
TL;DR: Riluzole seems to exert a beneficial effect only in the first 6 months of therapy, which is on the upper end of the wide range discussed in literature.
55
Finger dexterity deficits in Parkinson's disease and somatosensory cortical dysfunction
Thomas Foki,Walter Pirker,Alexander Geißler,Dietrich Haubenberger,Markus Hilbert,Ilse Hoellinger,Moritz C. Wurnig,Jakob Rath,Johann Lehrner,Eva Matt,Florian Ph. S. Fischmeister,Siegfried Trattnig,Eduard Auff,Roland Beisteiner +13 more
TL;DR: The results provide first evidence that dexterity deficits in PD are related to an S1 dysfunction which is insensitive to dopaminergic treatment.
43
Frequency and clinical features of treatment-refractory myasthenia gravis.
Jakob Rath,Ines Brunner,Matthias Tomschik,Gudrun Zulehner,E. Hilger,Martin Krenn,Anna Paul,Hakan Cetin,Fritz Zimprich +8 more
TL;DR: A small subgroup of patients with generalized myasthenia gravis do not respond sufficiently to standard therapies and are at higher risk for a refractory course, highlighting an unmet need for new treatment options.